HDAC9 and nasopharyngeal carcinoma: As HDAC can regulate mitochondrial function, it may be worth to test whether combined treatment with HDAC inhibitors and GSHEE would exhibit greater therapeutic benefit in NPC1 mutant mice with respect to either agent alone, supportingh this approach as a promising combination therapy for NPC.